Happiness Biotech Group, Ltd.
NASDAQ:
HAPP
Happiness Biotech Group, Ltd. is an innovative China-based nutraceutical and dietary supplements producer focused on the research, development, manufacturing, and marketing of a variety of products made from Chinese herbal extracts and others. Happiness Biotech conducts business in China through its wholly owned subsidiaries, mainly Fujian Happiness. Believing enhanced consumer awareness and demand for nutraceutical and dietary supplements, rising health care costs, aging populations, coupled with its effective sales have been the primary reasons for the company's growth throughout its 14 years of operating history.
Happiness Biotech is one of the leading companies in Fujian which specialize in research, development, manufacturing, and marketing of nutraceutical and dietary supplements authorized by Nutraceutical Association of Fujian Province. The products are categorized into six groups: Lucidum spore powder products, Cordyceps mycelia products, Ejiao solution products, Vitamins and dietary supplements products, American ginseng products, and others.
Lucidum spore powder products are targeted nutrition products with Lucidum spore powder as the main ingredient, mainly targeted to people with physical deficiencies and weak immune systems. Cordyceps mycelia products are targeted nutrition products with Cordyceps mycelia as the primary ingredient, mainly targeted to people with physical deficiencies and weak immune systems. Ejiao solution products are targeted nutrition products with donkey-hide gelatin, Astragalus Propinquus and Angelica sinensis as the main ingredients. Ejiao solution products mainly targets to people with physical deficiency, weak immune system, and nutritional anemia. Vitamins and dietary supplements products are daily dietary and nutritional supplements containing quality vitamins, minerals, and other natural ingredients, to supplement certain vitamins and minerals. American ginseng products are targeted nutrition products with American Ginseng, fructose, and honey as the main ingredients. Other products include nutraceutical and functional beverages containing quality herbs and other natural ingredients.
Over the past 14 years, Happiness Biotech has established a product portfolio consisting of 32 kinds of nutraceutical and dietary supplements products with "Blue Caps" approved by SFDA. Happiness Biotech has a sales network covering 20 provinces in China, with over 200 distributors and more than 20,000 sales terminals. The brand, "Happiness", is a well-known trademark in Fujian Province and well-recognized in the nutraceutical industry in China.
Happiness Biotech's objective is to provide the high-quality products to our consumers. It seeks to accomplish this goal through execution of significant investments in quality control, scientific personnel, product testing, and self-manufacturing of our products. Happiness Biotech's objective is rooted in using quality ingredients from traceable sources coupled with the continuous control during the manufacturing process of its products. Happiness Biotech produces all the products by itself without any outsourced subcontracting.
Key Facts
Auditor
Public Listing
Domicile
HQ/Management
Location of Key Operations
IR Contact
Briggs & Veselka
IPO (October 25, 2019)
Cayman Islands
Shunchang, Nanping, China
Ping Chen, Internal
86-599-7828808
Analyst Coverage
Latest News
September 24, 2021: Happiness Biotech Announced Another Electric Vehicle Transaction of Over $14 Million With Ruili - Sep 23, 2021
September 10, 2021: Happiness Biotech Announced The Launch of Its Lucidum Tablets on DouYin Mall - Sep 10, 2021
June 25, 2021: Happiness Biotech Announces $2.16 Million Registered Direct Offering To Strategic Investors - Jun 25, 2021
June 21, 2021: Happiness Biotech Launched Beta Version Of Happy Buy International, Promoting Cross-border E-Commerce SaaS Services - Jun 18, 2021
June 14, 2021: Happiness Biotech Signed Agreement To Distribute Volkswagen Electric Vehicles - Jun 14, 2021
June 10, 2021: Happiness Biotech Entered Into Electric Vehicle Distribution Agreement With Geely's Subsidiary - Jun 10, 2021
April 19, 2021: Happiness Biotech Officially Launched Cross-Border E-commerce Platform- Happy Buy International
April 13, 2021: Happiness Biotech Announces Record-High Sales of Over $14 Million On Its E-Commerce Business In March
February 17, 2021: Happiness Biotech Provides Update and Guidance on Sales of Its E-Commerce Business
February 2, 2021: Happiness Biotech Launched Auto Sales Platform "Happy Auto"
January 22, 2021: Happiness Biotech Announces Financial Results for the Six Months Ended September 30, 2020 and Provides Guidance For the Whole Fiscal Year Ending March 31, 2021
January 11, 2021: Happiness Biotech's E-Commerce Business - Happy Buy, Achieved Over 70% Growth in December
January 4, 2021: Happiness Biotech Announces Registered Direct Offering of up to 4.2 Million Ordinary Shares to Strategic Investors